1 reports of this reaction
1.9% of all APIS MELLIFERA reports
#6 most reported adverse reaction
ABDOMINAL PAIN is the #6 most commonly reported adverse reaction for APIS MELLIFERA, manufactured by Boiron. There are 1 FDA adverse event reports linking APIS MELLIFERA to ABDOMINAL PAIN. This represents approximately 1.9% of all 52 adverse event reports for this drug.
Patients taking APIS MELLIFERA who experience abdominal pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ABDOMINAL PAIN is a less commonly reported adverse event for APIS MELLIFERA, but still significant enough to appear in the safety profile.
In addition to abdominal pain, the following adverse reactions have been reported for APIS MELLIFERA:
The following drugs have also been linked to abdominal pain in FDA adverse event reports:
ABDOMINAL PAIN has been reported as an adverse event in 1 FDA reports for APIS MELLIFERA. This does not prove causation, but indicates an association observed in post-market surveillance data.
ABDOMINAL PAIN accounts for approximately 1.9% of all adverse event reports for APIS MELLIFERA, making it a notable side effect.
If you experience abdominal pain while taking APIS MELLIFERA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.